Related Experiment Video

Updated: May 8, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Role, Function and Therapeutic Potential of microRNAs in Vascular Aging

Felix Jansen, Xiaoyan Yang, Georg Nickenig

  • 1Medizinische Klinik und Poliklinik II, Universitatsklinikum Bonn, 53105 Bonn, Germany. mariuca.vasa-nicotera@ukb.uni-bonn.d.

Current Vascular Pharmacology
|August 15, 2013
PubMed

Insights

As people live longer, understanding how aging affects cardiovascular diseases is crucial. This review explores how microRNAs (miRs) regulate age-related vascular changes, offering insights into future treatments.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Aging Research

Background:

  • Global life expectancy is increasing, leading to a greater prevalence of age-related cardiovascular diseases.
  • Understanding the biological mechanisms of aging is essential for developing future cardiovascular disease interventions.
  • microRNAs (miRs) are key regulators in vascular pathologies like atherosclerosis and hypertension, with known links to aging.

Purpose of the Study:

  • To review the role of microRNAs (miRs) in age-associated cardiovascular pathologies.
  • To highlight the involvement of miRs in key aging processes affecting the vasculature.

Main Methods:

  • Literature review of studies investigating microRNAs and aging in cardiovascular disease.
  • Synthesis of current knowledge on miR regulation in age-related vascular dysfunction.

Main Results:

  • microRNAs (miRs) are implicated in several age-associated vascular conditions.
  • Specific miRs influence oxidative stress, vascular inflammation, vascular tone, endothelial cell senescence, and angiogenesis.
  • These miR-mediated pathways contribute significantly to the pathophysiology of cardiovascular diseases in aging individuals.

Conclusions:

  • microRNAs (miRs) are critical players in the aging cardiovascular system.
  • Targeting miRs presents a promising therapeutic strategy for age-related cardiovascular diseases.
  • Further research into miR function in vascular aging is warranted to combat future cardiovascular disease burdens.

More Related Videos

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...